SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nicholas Varthas who wrote (106)6/25/1998 1:30:00 AM
From: Sam Lee  Read Replies (1) of 320
 
I talked to the CEO about a month ago.I got the impression that they were waiting on contract approval.I know an analyst who follows them and he is of the same opinion.
Nyotran is first up and thereafter they have a great line of potential product.
I think Aronex thinks they have a deal subject to some details.And I have a lot of money bet that my GFA(gut feel analysis ) is correct.
If the market doesn't fall apart then I think $8 is possible this year.Some folks think it is worth that now just based on research value.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News